Dexamethasone: chondroprotective corticosteroid or catabolic killer?

Volume: 38, Pages: 246 - 263
Published: Nov 22, 2019
Abstract
While glucocorticoids have been used for over 50 years to treat rheumatoid and osteoarthritis pain, the prescription of glucocorticoids remains controversial because of potentially harmful side effects at the molecular, cellular and tissue levels. One member of the glucocorticoid family, dexamethasone (DEX) has recently been demonstrated to rescue cartilage matrix loss and chondrocyte viability in animal studies and cartilage explant models of...
Paper Details
Title
Dexamethasone: chondroprotective corticosteroid or catabolic killer?
Published Date
Nov 22, 2019
Volume
38
Pages
246 - 263
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.